Volume Alert - MDT 68.10 Medtronic Inc $MDT Hit a
Post# of 99
Posted On: 11/08/2014 1:20:15 AM
Volume Alert - MDT 68.10 Medtronic Inc $MDT Hit a high today of 68.86 Closing the day 11/07/14 at 68.10 -0.64 -0.93% With a day low of 67.79 and a total volume of 6,054,029.
MDT Recent Posts: http://investorshangout.com/Medtronic-Inc-MDT-51763/
MDT Medtronic Inc Recent Headline News
Final Glance: Medical Devices companies
AP - Fri Nov 07, 5:08PM CST
NEW YORK (AP) — Shares of some top medical devices companies were down at the close of trading:
ZMH: 108.19 (-2.00), JNJ: 108.20 (-0.81), MDT: 68.10 (-0.64), BAX: 70.61 (-0.99)
Midday Glance: Medical Devices companies
AP - Fri Nov 07, 12:18PM CST
NEW YORK (AP) — Shares of some top medical devices companies are down at 1 p.m.:
ZMH: 108.19 (-2.00), JNJ: 108.20 (-0.81), MDT: 68.10 (-0.64), BAX: 70.61 (-0.99)
Early Glance: Medical Devices companies
AP - Fri Nov 07, 9:54AM CST
NEW YORK (AP) — Shares of some top medical devices companies are down at 10 a.m.:
ZMH: 108.19 (-2.00), JNJ: 108.20 (-0.81), MDT: 68.10 (-0.64), BAX: 70.61 (-0.99)
The Zacks Analyst Blog Highlights: AbbVie, Shire, Medtronic, Unilife and Derma Sciences
PR Newswire - Fri Nov 07, 8:30AM CST
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the AbbVie Inc. (NYSE:ABBV-Free Report), Shire plc (Nasdaq:SHPG-Free Report), Medtronic Inc. (NYSE:MDT-Free Report), Unilife Corporation (Nasdaq:UNIS-Free Report) and Derma Sciences Inc. (Nasdaq
SCI-Free Report).
DSCI: 9.06 (+0.06), UNIS: 3.58 (+0.09), MDT: 68.10 (-0.64), SHPG: 198.58 (-1.37)
Study Results, Financial Results, Regulatory Updates, and Upcoming Conference - Research Reports on Medtronic, Zoetis, Biogen, Tenet Health and Aetna
PR Newswire - Fri Nov 07, 7:55AM CST
Today, Analysts Review released its research reports regarding Medtronic, Inc. (NYSE: MDT), Zoetis Inc. (NYSE: ZTS), Biogen Idec Inc. (NASDAQ: BIIB), Tenet Healthcare Corp. (NYSE: THC) and Aetna Inc. (NYSE: AET). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7776-100free.
ZTS: 40.23 (+0.52), BIIB: 320.75 (-2.72), MDT: 68.10 (-0.64), THC: 47.85 (-3.33), AET: 82.29 (-2.41)
Global Bio-implants Market (Types, and geography) - Forecast to 2020
M2 - Fri Nov 07, 6:14AM CST
Research and Markets (http://www.researchandmarkets.com/research/57vlzn/global) has announced the addition of the "Global Bio-implants Market (Types, and geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020 " report to their offering. Bio-implants have emerged as a promising solution for the variety of conditions such as cardiovascular, dental, orthopedic, ophthalmology, neurological disorders and others. Global bio implants market is forecast to reach $115.8 billion by 2020. High prevalence of disease conditions such as cardiovascular, orthopedic and spinal disorders that can be treated via bio implants are the key drivers of the bio implants market. According to American College Of Surgeons, 29% of the trauma injuries were caused by road accidents; the instances of road accidents and death due to the same are rising to about 2.2% globally. Such patients undergoing traumatic injuries can be effectively treated with bio implants. Such afore-mentioned factor and multifarious analogous factors across cardiovascular, spinal and ophthalmic disorders drive the growth of the bio implants market. The global bio-implants market is segmented based on product types and geography. Within the product types, the bio implants market is segmented into cardiovascular, dental and prosthetic implants, orthopedic/joint reconstruction and replacement bio implants, spinal bio implants, ophthalmology bio implants and others. Geographically, the market is segmented into four regions, namely North America, Europe, Asia-Pacific and LAMEA. Key Topics Covered: CHAPTER 1 INTRODUCTION CHAPTER 2 EXECUTIVE SUMMARY CHAPTER 3 GLOBAL BIOIMPLANTS MARKET OVERVIEW CHAPTER 4 GLOBAL BIO IMPLANTS MARKET BY TYPES CHAPTER 5 GLOBAL BIO IMPLANTS MARKET BY GEOGRAPHY CHAPTER 6 EUROPEAN BIO IMPLANTS MARKET ANALYSIS CHAPTER 7 COMPANY PROFILE Companies Mentioned: - B.Braun - BIOMET (Zimmer) - Biotroni - DENTSPLY International - DePuy Synthes - Ethicon Inc. - Invibio Biomaterial Solutions - kasios - KLS Martin - Mediplus - Medtronic, Inc. - SBM (Science for Biomaterials) - Smith & Nephews - Stryker Corporation - Wright Medical Group For more information visit http://www.researchandmarkets.com/research/57vlzn/global
MDT: 68.10 (-0.64), WMGIZ: 4.31 (-0.04), XRAY: 51.25 (-0.88), SYK: 87.47 (-1.08)
Top 2 MedTech Stocks, Poised to Gain on Earnings this Season - Earnings ESP
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 9:36AM CST
Medical device is one of such sectors which are projected to be highly affected by the midterm election results.
DSCI: 9.06 (+0.06), MDT: 68.10 (-0.64), UNIS: 3.58 (+0.09), COV: 92.08 (-0.52), SHPG: 198.58 (-1.37), ABBV: 61.50 (-1.21), WAG: 66.92 (+0.27)
'Fast Money' Recap: Tesla's a Buy Despite the 4Q Guidance
at The Street - Thu Nov 06, 4:00AM CST
The trading panel discussed earnings reports from Tesla, Whole Foods Market and Qualcomm.
WFM: 46.81 (+1.96), TSLA: 240.20 (-1.02), FEYE: 30.62 (+0.58), MDT: 68.10 (-0.64), OIH: 45.00 (+0.72), QCOM: 69.26 (-1.32), SO: 47.13 (+0.12), PANW: 107.02 (+0.91)
After Yesterday's Rally of 1.13% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Wed Nov 05, 3:45PM CST
Medtronic (NYSE:MDT) traded in a range yesterday that spanned from a low of $68.28 to a high of $69.01. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $68.41 on volume of 11.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
MDT: 68.10 (-0.64)
SmarTrend Watching for Potential Pullback in Shares of Medtronic After 1.13% Gain
Comtex SmarTrend(R) - Wed Nov 05, 3:44PM CST
Medtronic (NYSE:MDT) traded in a range yesterday that spanned from a low of $68.28 to a high of $69.01. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $68.41 on volume of 11.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
MDT: 68.10 (-0.64)
Covidien (COV) Beats on Q4 Earnings, Sales; Both Up Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 1:50PM CST
Covidien plc (COV) reported fourth-quarter fiscal 2014 earnings of $1.15 per share, which beat the Zacks Consensus Estimate by 14 cents.
MDT: 68.10 (-0.64), GWPH: 73.97 (-0.41), ABAX: 51.63 (-2.21), COV: 92.08 (-0.52)
GOP Win Lifts TransCanada, Medical Device, Coal Stocks
at Investor's Business Daily - Wed Nov 05, 1:35PM CST
Prospects for approval of the Keystone XL pipeline, and for Calgary-based pipeline operator TransCanada (TRP), brightened after the GOP gained control of the Senate Tuesday. The power shift in Washington is also expected to benefit medical device...
BSX: 13.24 (-0.12), BTU: 11.64 (+0.80), MDT: 68.10 (-0.64), TRP: 49.40 (+0.18), STJ: 64.76 (-1.28), ANR: 2.91 (+0.39)
Medtronic (MDT) Breaks Through Resistance at $68.35
Comtex SmarTrend(R) - Wed Nov 05, 8:57AM CST
Shares of Medtronic (NYSE:MDT) have bullishly opened above the pivot of $67.87 today and have reached the first resistance level of $68.35. Analysts will be watching for a cross of the next upside pivot targets of $68.77 and $69.67.
MDT: 68.10 (-0.64)
Republicans Grab Senate: Which Stocks Will Fare Well? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 8:19AM CST
The Republican win will certainly bolster stocks and give investors more chances to earn.
GD: 140.14 (-1.42), LMT: 186.15 (-3.73), MDT: 68.10 (-0.64), QDEL: 27.87 (-0.80), XOM: 96.59 (+0.33), CLF: 11.17 (+0.63), BA: 124.45 (-0.13), NUVA: 41.75 (-0.18), ANR: 2.91 (+0.39), BSX: 13.24 (-0.12), VLO: 50.72 (+0.48), BTU: 11.64 (+0.80), ABAX: 51.63 (-2.21), IMO: 47.63 (+0.74), ACI: 2.86 (+0.44)
New Harvard Business Review Insight Center, Sponsored by Medtronic, Features Online Forum Focused on Innovating for Value in Healthcare
Thomson Reuters ONE - Wed Nov 05, 8:01AM CST
MINNEAPOLIS, Nov. 5, 2014 - Today marks the launch of a new Harvard Business Review (HBR) Insight Center, exclusively sponsored by Medtronic, which provides a forum for thought-leading commentary, editorial content and dialogue focused on innovating for value in healthcare. The Insight Center is a collaboration between HBR and the New England Journal of Medicine (NEJM) and provides an online forum for leaders, managers and others in healthcare.
MDT: 68.10 (-0.64)
Covidien to Sell Stellarex DCB to Spectranetics for $30M - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 5:07PM CST
Divesture of Covidien plc's (COV) Stellarex DCB is subject to the approval of the Federal Trade Commission and other regulatory agencies, as well as closure of the Medtronic-Covidien merger, which is slated to complete by early 2015.
BCR: 162.38 (-2.59), MDT: 68.10 (-0.64), GWPH: 73.97 (-0.41), COV: 92.08 (-0.52)
MDT Recent Posts: http://investorshangout.com/Medtronic-Inc-MDT-51763/
MDT Medtronic Inc Recent Headline News
Final Glance: Medical Devices companies
AP - Fri Nov 07, 5:08PM CST
NEW YORK (AP) — Shares of some top medical devices companies were down at the close of trading:
ZMH: 108.19 (-2.00), JNJ: 108.20 (-0.81), MDT: 68.10 (-0.64), BAX: 70.61 (-0.99)
Midday Glance: Medical Devices companies
AP - Fri Nov 07, 12:18PM CST
NEW YORK (AP) — Shares of some top medical devices companies are down at 1 p.m.:
ZMH: 108.19 (-2.00), JNJ: 108.20 (-0.81), MDT: 68.10 (-0.64), BAX: 70.61 (-0.99)
Early Glance: Medical Devices companies
AP - Fri Nov 07, 9:54AM CST
NEW YORK (AP) — Shares of some top medical devices companies are down at 10 a.m.:
ZMH: 108.19 (-2.00), JNJ: 108.20 (-0.81), MDT: 68.10 (-0.64), BAX: 70.61 (-0.99)
The Zacks Analyst Blog Highlights: AbbVie, Shire, Medtronic, Unilife and Derma Sciences
PR Newswire - Fri Nov 07, 8:30AM CST
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the AbbVie Inc. (NYSE:ABBV-Free Report), Shire plc (Nasdaq:SHPG-Free Report), Medtronic Inc. (NYSE:MDT-Free Report), Unilife Corporation (Nasdaq:UNIS-Free Report) and Derma Sciences Inc. (Nasdaq
SCI-Free Report). DSCI: 9.06 (+0.06), UNIS: 3.58 (+0.09), MDT: 68.10 (-0.64), SHPG: 198.58 (-1.37)
Study Results, Financial Results, Regulatory Updates, and Upcoming Conference - Research Reports on Medtronic, Zoetis, Biogen, Tenet Health and Aetna
PR Newswire - Fri Nov 07, 7:55AM CST
Today, Analysts Review released its research reports regarding Medtronic, Inc. (NYSE: MDT), Zoetis Inc. (NYSE: ZTS), Biogen Idec Inc. (NASDAQ: BIIB), Tenet Healthcare Corp. (NYSE: THC) and Aetna Inc. (NYSE: AET). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7776-100free.
ZTS: 40.23 (+0.52), BIIB: 320.75 (-2.72), MDT: 68.10 (-0.64), THC: 47.85 (-3.33), AET: 82.29 (-2.41)
Global Bio-implants Market (Types, and geography) - Forecast to 2020
M2 - Fri Nov 07, 6:14AM CST
Research and Markets (http://www.researchandmarkets.com/research/57vlzn/global) has announced the addition of the "Global Bio-implants Market (Types, and geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020 " report to their offering. Bio-implants have emerged as a promising solution for the variety of conditions such as cardiovascular, dental, orthopedic, ophthalmology, neurological disorders and others. Global bio implants market is forecast to reach $115.8 billion by 2020. High prevalence of disease conditions such as cardiovascular, orthopedic and spinal disorders that can be treated via bio implants are the key drivers of the bio implants market. According to American College Of Surgeons, 29% of the trauma injuries were caused by road accidents; the instances of road accidents and death due to the same are rising to about 2.2% globally. Such patients undergoing traumatic injuries can be effectively treated with bio implants. Such afore-mentioned factor and multifarious analogous factors across cardiovascular, spinal and ophthalmic disorders drive the growth of the bio implants market. The global bio-implants market is segmented based on product types and geography. Within the product types, the bio implants market is segmented into cardiovascular, dental and prosthetic implants, orthopedic/joint reconstruction and replacement bio implants, spinal bio implants, ophthalmology bio implants and others. Geographically, the market is segmented into four regions, namely North America, Europe, Asia-Pacific and LAMEA. Key Topics Covered: CHAPTER 1 INTRODUCTION CHAPTER 2 EXECUTIVE SUMMARY CHAPTER 3 GLOBAL BIOIMPLANTS MARKET OVERVIEW CHAPTER 4 GLOBAL BIO IMPLANTS MARKET BY TYPES CHAPTER 5 GLOBAL BIO IMPLANTS MARKET BY GEOGRAPHY CHAPTER 6 EUROPEAN BIO IMPLANTS MARKET ANALYSIS CHAPTER 7 COMPANY PROFILE Companies Mentioned: - B.Braun - BIOMET (Zimmer) - Biotroni - DENTSPLY International - DePuy Synthes - Ethicon Inc. - Invibio Biomaterial Solutions - kasios - KLS Martin - Mediplus - Medtronic, Inc. - SBM (Science for Biomaterials) - Smith & Nephews - Stryker Corporation - Wright Medical Group For more information visit http://www.researchandmarkets.com/research/57vlzn/global
MDT: 68.10 (-0.64), WMGIZ: 4.31 (-0.04), XRAY: 51.25 (-0.88), SYK: 87.47 (-1.08)
Top 2 MedTech Stocks, Poised to Gain on Earnings this Season - Earnings ESP
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 9:36AM CST
Medical device is one of such sectors which are projected to be highly affected by the midterm election results.
DSCI: 9.06 (+0.06), MDT: 68.10 (-0.64), UNIS: 3.58 (+0.09), COV: 92.08 (-0.52), SHPG: 198.58 (-1.37), ABBV: 61.50 (-1.21), WAG: 66.92 (+0.27)
'Fast Money' Recap: Tesla's a Buy Despite the 4Q Guidance
at The Street - Thu Nov 06, 4:00AM CST
The trading panel discussed earnings reports from Tesla, Whole Foods Market and Qualcomm.
WFM: 46.81 (+1.96), TSLA: 240.20 (-1.02), FEYE: 30.62 (+0.58), MDT: 68.10 (-0.64), OIH: 45.00 (+0.72), QCOM: 69.26 (-1.32), SO: 47.13 (+0.12), PANW: 107.02 (+0.91)
After Yesterday's Rally of 1.13% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Wed Nov 05, 3:45PM CST
Medtronic (NYSE:MDT) traded in a range yesterday that spanned from a low of $68.28 to a high of $69.01. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $68.41 on volume of 11.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
MDT: 68.10 (-0.64)
SmarTrend Watching for Potential Pullback in Shares of Medtronic After 1.13% Gain
Comtex SmarTrend(R) - Wed Nov 05, 3:44PM CST
Medtronic (NYSE:MDT) traded in a range yesterday that spanned from a low of $68.28 to a high of $69.01. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $68.41 on volume of 11.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
MDT: 68.10 (-0.64)
Covidien (COV) Beats on Q4 Earnings, Sales; Both Up Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 1:50PM CST
Covidien plc (COV) reported fourth-quarter fiscal 2014 earnings of $1.15 per share, which beat the Zacks Consensus Estimate by 14 cents.
MDT: 68.10 (-0.64), GWPH: 73.97 (-0.41), ABAX: 51.63 (-2.21), COV: 92.08 (-0.52)
GOP Win Lifts TransCanada, Medical Device, Coal Stocks
at Investor's Business Daily - Wed Nov 05, 1:35PM CST
Prospects for approval of the Keystone XL pipeline, and for Calgary-based pipeline operator TransCanada (TRP), brightened after the GOP gained control of the Senate Tuesday. The power shift in Washington is also expected to benefit medical device...
BSX: 13.24 (-0.12), BTU: 11.64 (+0.80), MDT: 68.10 (-0.64), TRP: 49.40 (+0.18), STJ: 64.76 (-1.28), ANR: 2.91 (+0.39)
Medtronic (MDT) Breaks Through Resistance at $68.35
Comtex SmarTrend(R) - Wed Nov 05, 8:57AM CST
Shares of Medtronic (NYSE:MDT) have bullishly opened above the pivot of $67.87 today and have reached the first resistance level of $68.35. Analysts will be watching for a cross of the next upside pivot targets of $68.77 and $69.67.
MDT: 68.10 (-0.64)
Republicans Grab Senate: Which Stocks Will Fare Well? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 8:19AM CST
The Republican win will certainly bolster stocks and give investors more chances to earn.
GD: 140.14 (-1.42), LMT: 186.15 (-3.73), MDT: 68.10 (-0.64), QDEL: 27.87 (-0.80), XOM: 96.59 (+0.33), CLF: 11.17 (+0.63), BA: 124.45 (-0.13), NUVA: 41.75 (-0.18), ANR: 2.91 (+0.39), BSX: 13.24 (-0.12), VLO: 50.72 (+0.48), BTU: 11.64 (+0.80), ABAX: 51.63 (-2.21), IMO: 47.63 (+0.74), ACI: 2.86 (+0.44)
New Harvard Business Review Insight Center, Sponsored by Medtronic, Features Online Forum Focused on Innovating for Value in Healthcare
Thomson Reuters ONE - Wed Nov 05, 8:01AM CST
MINNEAPOLIS, Nov. 5, 2014 - Today marks the launch of a new Harvard Business Review (HBR) Insight Center, exclusively sponsored by Medtronic, which provides a forum for thought-leading commentary, editorial content and dialogue focused on innovating for value in healthcare. The Insight Center is a collaboration between HBR and the New England Journal of Medicine (NEJM) and provides an online forum for leaders, managers and others in healthcare.
MDT: 68.10 (-0.64)
Covidien to Sell Stellarex DCB to Spectranetics for $30M - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 5:07PM CST
Divesture of Covidien plc's (COV) Stellarex DCB is subject to the approval of the Federal Trade Commission and other regulatory agencies, as well as closure of the Medtronic-Covidien merger, which is slated to complete by early 2015.
BCR: 162.38 (-2.59), MDT: 68.10 (-0.64), GWPH: 73.97 (-0.41), COV: 92.08 (-0.52)
(0)
(0)Medtronic, Inc. (MDT) Stock Research Links
Scroll down for more posts ▼